News | Breast Imaging | November 08, 2016

VolparaEnterprise Software to Help Breast Imaging Providers Comply With New FDA Quality Initiative

Volpara’s “EQUIP-ready” support program will help accredited breast imaging centers meet requirements of recently enacted Enhacing Quality Using the Inspection Program (EQUIP) initiative

Volpara Solutions, VolparaEnterprise, breast imaging software, EQUIP-ready support program, FDA, Enhancing Quality Using the Inspection Program

November 8, 2016 — Volpara Solutions announced the launch of a support program to help accredited breast imaging centers across the United States prepare for compliance to the U.S. Food and Drug Administration’s (FDA) Enhancing Quality Using the Inspection Program (EQUIP) initiative. The Volpara "EQUIP-ready" program — which includes draft processes, procedures and forms designed to help users accelerate their compliance efforts — is included with the company's Volpara Enterprise cloud-based quality assurance solution.

The EQUIP initiative, launched on Oct. 27, 2016 to coincide with the 25th anniversary of the passage of the Mammography Quality Standards Act (MQSA), emphasizes "the need for ongoing facility review of clinical image quality." Beginning in 2017, accredited breast screening providers will have to address three new questions to ensure compliance with regulations relating to quality assurance in the FDA's annual facility inspections. Every facility will need to demonstrate that it has:

  1. A corrective action system that can address when clinical images are of poor quality;
  2. A means of establishing that clinical images continue to comply with the standards of its accreditation body, including quality attributes such as positioning, and include regular reviews of sample images from each technologist and each interpreting physician; and
  3. A procedure for oversight of quality assurance/quality control (QA/QC) records and corrective actions.

VolparaEnterprise software — which delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including positioning, compression and equipment utilization — is designed to help sites prepare for the EQUIP inspection questions:

  • The software monitors every screening mammogram for image quality issues related to positioning and compression;
  • VolparaEnterprise data's easy sorting by technologist helps isolate cases for EQUIP review; and
  • It can help rapidly locate poor quality images for review during Image Review Quality Meetings (as well as good-quality images for review in preparation for machine accreditation).

Designed to support large or small enterprises, VolparaEnterprise software enables breast imaging providers to provide objective evidence to demonstrate compliance and quality of care. Users can perform rapid quality control checks to optimize the productivity and efficiency of imaging resources, to help reduce costs through the reduction of retakes, and to increase staff effectiveness. The Microsoft Azure–based solution provides real-time quality assurance and performance monitoring through dynamic, interactive dashboards. 

For more information: www.volparasolutions.com

Related Content

Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...